Oxbridge Re (OXBR) to Release Earnings on Monday

Oxbridge Re (NASDAQ:OXBR) will likely be releasing its Q4 2025 results after the market closes on Monday, March 30th. Analysts expect Oxbridge Re to post earnings of ($0.02) per share and revenue of $0.70 million for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Monday, March 30, 2026 at 4:30 PM ET.

Oxbridge Re Stock Performance

OXBR stock opened at $0.89 on Friday. Oxbridge Re has a one year low of $0.76 and a one year high of $2.86. The firm’s fifty day moving average is $1.04 and its 200 day moving average is $1.39. The firm has a market cap of $6.82 million, a PE ratio of -2.61 and a beta of 2.27.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Oxbridge Re in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $5.00.

Institutional Investors Weigh In On Oxbridge Re

An institutional investor recently raised its position in Oxbridge Re stock. J.W. Cole Advisors Inc. boosted its stake in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR) by 106.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 68,000 shares of the insurance provider’s stock after acquiring an additional 35,000 shares during the period. J.W. Cole Advisors Inc. owned about 0.89% of Oxbridge Re worth $90,000 at the end of the most recent quarter. 5.64% of the stock is owned by institutional investors.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.